{"url":"https://lda.senate.gov/api/v1/filings/087a558a-e6af-4bad-b3b1-c1b3c2da9dd2/","filing_uuid":"087a558a-e6af-4bad-b3b1-c1b3c2da9dd2","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2016,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/087a558a-e6af-4bad-b3b1-c1b3c2da9dd2/print/","filing_document_content_type":"text/html","income":null,"expenses":"331555.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"HEIDI L. WAGNER","dt_posted":"2017-01-23T13:28:40-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 College Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"New Haven","registrant_state":"CT","registrant_zip":"06510","registrant":{"id":400504482,"url":"https://lda.senate.gov/api/v1/registrants/400504482/","house_registrant_id":null,"name":"ALEXION PHARMACEUTICALS, INC.","description":"Global biopharmaceutical company","address_1":"121 Seaport Boulevard","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATIE JONES","contact_telephone":"+1 857-338-8786","dt_updated":"2022-04-06T16:08:35.175195-04:00"},"client":{"id":191954,"url":"https://lda.senate.gov/api/v1/clients/191954/","client_id":12,"name":"ALEXION PHARMACEUTICALS, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-10-01"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Corporate tax reform\nOrphan Drug Tax Credit\nExpiring tax provisions\nPatent Box","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56169,"prefix":null,"prefix_display":null,"first_name":"VANESSA","nickname":null,"middle_name":null,"last_name":"PROCTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64224,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":null,"last_name":"OWANO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"TTP\nTTIP\nTPA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61262,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"KALBAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":52061,"prefix":"ms","prefix_display":"MS.","first_name":"HEIDI","nickname":null,"middle_name":"L","last_name":"WAGNER","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CMS Part B DEMO \nCMMI\nMedicaid Reform; Texas Medicaid\nMedicare Hospital Inpatient Payment Reform","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":52061,"prefix":"ms","prefix_display":"MS.","first_name":"HEIDI","nickname":null,"middle_name":"L","last_name":"WAGNER","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false},{"lobbyist":{"id":56169,"prefix":null,"prefix_display":null,"first_name":"VANESSA","nickname":null,"middle_name":null,"last_name":"PROCTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64224,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":null,"last_name":"OWANO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug Pricing\nCreates ACT (REMs)\nCURES\nAdvancing Hope Act (PRV Reauthorization)\nACA Implementation Issues\nPDUFA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":52061,"prefix":"ms","prefix_display":"MS.","first_name":"HEIDI","nickname":null,"middle_name":"L","last_name":"WAGNER","suffix":"esq","suffix_display":"ESQ"},"covered_position":null,"new":false},{"lobbyist":{"id":56169,"prefix":null,"prefix_display":null,"first_name":"VANESSA","nickname":null,"middle_name":null,"last_name":"PROCTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64224,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":null,"last_name":"OWANO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}